The Journal, Rheumatology International recently featured a study that evaluated “the roles of sociocultural status, distress and cognitive functions in rheumatoid arthritis (RA) patients who developed methotrexate (MTX)-related neutropenia.” The study consisted of 74 (age 60 and older) older adults diagnosed with rheumatoid arthritis. The Authors found that “low socioeconomical status and older age are associated with serious toxicity in RA patients using MTX” and that “measures should be taken to prevent wrong MTX dosing among patients.”
